Authors: SCHWARTSMANN G HOROWITZ M DILEONE L SANDER E CAMPOS O FERREIRA AF SCHUNEMANN H VIEGAS MAV CANCELA AI MANS DRA

Citation: G. Schwartsmann et al., PHASE-I TRIAL OF THE BOMBESIN RECEPTOR ANTAGONIST RC-3095 IN PATIENTSWITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 651-651

Authors: SCHWARTSMANN G DILEONE L CALDAS APF CAMPOS O CANCELA AI VIEGAS MAV MANS DRA

Citation: G. Schwartsmann et al., PHASE-I AND PHARMACOKINETIC STUDY OF LOW-DOSE, 3-TIMES DAILY ORAL ETOPOSIDE IN PATIENTS WITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 660-660

Authors: SCHWARTSMANN G MANS DRA DILEONE L CALDAS APF CAMPOS O SANDER E BORTOLINI M VIEGAS MAV CANCELA AI

Citation: G. Schwartsmann et al., PHASE-I AND PHARMACOKINETIC STUDY OF ORAL ETOPOSIDE GIVEN 3-TIMES DAILY ORALLY TO PATIENTS WITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 252-252

Authors: SCHWARTSMANN G HOROWITZ M DILEONE L SANDER E CAMPOS O FERREIRA AF SCHUNEMANN H VIEGAS MAV CANCELA AI MANS DRA

Citation: G. Schwartsmann et al., PHASE-I TRIAL OF THE BOMBESIN RECEPTOR ANTAGONIST RC-3095 IN PATIENTSWITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 420-420

Authors: SCHWARTSMANN G FERNANDES MS SCHAAN MD MOSCHEN M GERHARDT LM DILEONE L LOITZEMBAUER B KALAKUN L

Citation: G. Schwartsmann et al., DECITABINE (5-AZA-2'-DEOXYCYTIDINE, DAC) PLUS DAUNORUBICIN AS A FIRSTLINE TREATMENT IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA - PRELIMINARY-OBSERVATIONS, Leukemia, 11, 1997, pp. 28-31

Authors: SCHWARTSMANN G SPRINZ E KROMFIELD M KALAKUN L SANDER E PROLLA G DILEONE L GERHARDT L MANS DRA

Citation: G. Schwartsmann et al., CLINICAL AND PHARMACOKINETIC STUDY OF ORAL ETOPOSIDE IN PATIENTS WITHAIDS-RELATED KAPOSIS-SARCOMA WITH NO PRIOR EXPOSURE TO CYTOTOXIC THERAPY, Journal of clinical oncology, 15(5), 1997, pp. 2118-2124